Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IAnne Puel, Jean‐Laurent Casanova, Gabriela Barcenas‐Morales et al.|The Journal of Experimental Medicine|2010Cited by 721
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutationsLisa R. Forbes, Jennifer W. Leiding, Tiphanie P. Vogel et al.|Journal of Allergy and Clinical Immunology|2018Cited by 261